|
Zentiva N.V. - Company Profile Snapshot
| Company Profile: |
Zentiva N.V. |
| Ticker: |
BAAZEN |
| Exchanges: |
OTH PRG |
| 2008 Sales: |
736,400,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
NETHERLANDS |
| Employees: |
6355 |
Business Description
Zentiva N.V.. The Group's principal activities are producing, developing and selling of generic pharmaceuticals, including pharmaceutical chemicals, cosmetics and packaging for pharmaceutical products and special purpose equipment and machines for the pharmaceutical industry. The Group's main operations are based on Czech Republic, Slovak Republic, the Baltic states, Romania, Bulgaria, Moldavia and the Commonwealth of independent states. Some branded pharmaceutical products manufactured by the group include: Helicid, Lozap, Torvacard, Simvacard and Ibalgin. On Mar 5, 2007, the Group signed an agreement to acquire 75% of the issued capital of Eczacibasi Generic Pharmaceuticals, a pharmaceutical company in Turkey.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
